RecruitingNot ApplicableNCT07308418

The Influence of Vibrotactile Stimulation on Self-selected Walking Speed in People With Parkinson's Disease


Sponsor

Magnes AG

Enrollment

16 participants

Start Date

Jan 10, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

The study tests whether a smart shoe (NUSHU) that provides vibrotactile stimulation can improve walking speed in people with Parkinson's disease. Sixteen participants complete two short walking tests-with and without vibration-to compare gait speed, cadence, stride length, usability, and safety. It is a low-risk pilot study meant to generate first evidence for future research.


Eligibility

Min Age: 18 Years

Inclusion Criteria6

  • A medically confirmed diagnosis of Parkinson's disease on the physiotherapy prescription.
  • Stable medication for at least four weeks (no change in dopaminergic therapy).
  • The ability to walk at least 200 metres without stopping.
  • Minimum age: 18 years
  • Sufficient knowledge of German to understand the study information and complete the questionnaires.
  • Written informed consent form

Exclusion Criteria4

  • Atypical or secondary Parkinsonism
  • Sensory disturbances in the feet (e.g. polyneuropathy).
  • Other neurological, orthopaedic or internal medical conditions that significantly affect walking
  • Cognitive impairments that interfere with understanding the study information or following instructions

Interventions

DEVICEVibrotactile feedback during walking

NUSHU smart shoes give real time gait feedback during walking.


Locations(1)

Magnes AG

Zurich, Canton of Zurich, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07308418


Related Trials